SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions $MSI is trending as traders discuss a large dark pool transaction, with some speculating it could signal a bottom. Community members are also noting positive divergences and increasing volume. Bullish sentiment is further fueled by an increase in the regular quarterly dividend by 11 percent.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi is trending amid speculation around potential acquisitions and partnerships within the weight loss and obesity market, particularly fueled by discussions surrounding Altimmune on Stocktwits. The community is buzzing with buyout rumors involving companies like $GUTS, $TERN, and $VKTX, as well as existing connections with $IMRX, with some suggesting Sanofi is gearing up for a buying spree to compete with Novo Nordisk and Eli Lilly. Community members are closely monitoring upcoming data releases and strategic moves that could position Sanofi as a leader in this competitive landscape.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as discussion centers on its potential as a high-throughput, compliance-first settlement layer, with some highlighting its infrastructure-style approach and Eric Schmidt's backing; community members are comparing Keeta to existing blockchains like NEAR, Solana, and Bitcoin. Unlike other chains, Keeta aims to provide compliant rails for institutions and regulated capital, enabling interoperability between traditional finance and existing crypto ecosystems. The community also notes listing to a major CEX coming soon.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBAR is trending as the community discusses its potential and real-world utility, highlighting its enterprise adoption and governance structure. Recent discussions involve its comparison to Keeta, with some investors viewing Keeta as complementary infrastructure. Despite positive sentiment, some traders express concern about short-term price action and potential market manipulation.

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial, research and development, quality and process control settings. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company continuously increases its depth of capabilities across its broad portfolio of innovative products and services and leverages its extensive global channels to address customers’ needs. The company does this through organic investments in research and development, capacity and capabilities and through acquisitions. The company’s goal is to enable its customers to be more productive in an increasingly competitive business environment, enable them to accelerate innovation, solve their challenges and advance their important work. The company’s history roots back to the year 1956 when the business was first established. Thermo Fisher Scientific was formed in 2006 from the merger of Thermo Electron and Fisher Scientific and is headquartered in Waltham, MA.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific ($TMO) is trending due to a mix of factors, including options activity, analyst ratings, and discussions around potential acquisitions. Community members are actively debating the stock's recent performance, dissecting earnings forecasts, and analyzing its strategic partnerships, such as the one with Mainz Biomed ($MYNZ), as potential growth catalysts.  Additionally, mentions of insider selling and shifting market dynamics within the healthcare sector contribute to the ongoing conversation surrounding $TMO.

Sportradar Group AG engages in the provision of sports betting and entertainment products and services. Its products include Betting Technology & Solutions and Sports Content, Technology & Services. The company was founded by Carsten Marcus Koerl in 2001 and is headquartered in St. Gallen, Switzerland.

Sportradar Group AG - Ordinary Shares - Class A

SRAD is trending due to a cautious report from The Bear Cave, raising concerns about rising competition, challenges from prediction markets, and potential involvement in gambling corruption, countered by some in the investment community highlighting the company's solid cash flow, profitability, and growth potential, as well as Wells Fargo initiating coverage at Overweight. Community members are actively debating the validity of the Bear Cave report and the company's long-term prospects in the sports betting landscape, with some suggesting it's an attempt at market manipulation. The broader discussion involves prediction markets and their potential impact on SRAD's business model.

Mason Capital Fund Trust - Fundamentals First ETF

KNOW Labs is trending due to discussions around its potential listing on a major exchange like NASDAQ or NYSE, with investors reviewing SEC filings and insider activity. The community is also comparing KNOW's non-invasive glucose monitoring technology to competitors, highlighting potential advantages and expressing anticipation for future developments. Additionally, some are discussing seasonality trends.

BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.

BioHarvest Sciences Inc

BioHarvest Sciences ($BHST) is trending due to discussions around a recent public offering priced at $7/share, leading to concerns about potential dilution; Despite this, the community is actively debating the company's long-term potential, citing its unique botanical synthesis technology, CDMO division, and upcoming product launches like the olive oil supplement as reasons for optimism; Some investors are closely watching for news on the hydration drink release and anticipating volume based on positive trends.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1951 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture (ACN) is trending amidst discussions about AI strategy, potential acquisitions, and recent partnerships. Community members are weighing ACN's AI push against concerns about government contracts and competition in the IT consulting space. Options traders are also active, with both bullish and bearish positions being highlighted.

MIND Technology, Inc. engages in the provision of technology and solutions for exploration, survey and defense applications in oceanographic, hydrographic, defense, seismic and security industries. The firm’s Marine Technology products business consists of the design, manufacture, and sale of specialized marine seismic equipment, side scan sonar, water-side security systems, and the equipment sales activities of its Australian subsidiary, Seismic Asia Pacific Pty Ltd. The company was founded in 1987 and is headquartered in The Woodlands, TX.

MIND Technology Inc

MIND Technology is trending as investors discuss its potential in seabed exploration and mapping, particularly for rare earth minerals, with community members pointing to contracts, exploration activities, and government initiatives as catalysts. Community members debate earnings, short interest, and potential catalysts, including possible M&A activity. The discussion is set against the backdrop of ongoing technological developments in exploration and mapping and regulatory efforts to streamline seabed mineral development.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$QNTM been thinking about buying more but not seeing any signs of the bottom yet.  Further, losing some confidence in management at this point.  Biggest thing they have done in a long time is offer a reward for info on manipulation

$QNTM  I agree with you.  Management has got to get their heads out of their a**es.  The only PR&#39;s they issue are for bonusing themselves more shares and as you mentioned, offering a reward for proof of spoofing.  Unreal.  Need real news, real advancements in their business lines, etc......IMO of course.

StockTwits Web

StockTwits for iOS

Quantum BioPharma Ltd

 been thinking about buying more but not seeing any signs of the bottom yet.  Further, losing some confidence in management at this point.  Biggest thing they have done in a long time is offer a reward for info on manipulation